NCT03420521 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03420521
Title	Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors
Recruitment	Terminated
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications	neuroendocrine tumor gastrointestinal neuroendocrine tumor pulmonary neuroendocrine tumor
Therapies	Ipilimumab + Nivolumab
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 1 of 1 entries

Facility	Status	City	State	Zip	Country	Details
Johns Hopkins Medical Institution		Baltimore	Maryland	21287	United States	Details

Showing 1 to 1 of 1 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT03420521Clinical Trial Detail